|
Q2 2022
Filed on Aug 08, 2022
|
330
|
$56.16 - $65.68
$18.5K - $21.7K
|
|
|
Q2 2022
Filed on Aug 08, 2022
|
32
|
$28.05 - $39.51
$898 - $1.26K
|
|
|
Q2 2022
Filed on Aug 08, 2022
|
400
|
$6.17 - $10.9
$2.47K - $4.36K
|
|
|
Q2 2022
Filed on Aug 08, 2022
|
302
|
$64.66 - $90.71
$19.5K - $27.4K
|
|
|
Q2 2022
Filed on Aug 08, 2022
|
950
|
N/A
|
|
|
Q2 2022
Filed on Aug 08, 2022
|
428
|
$27.62 - $40.65
$11.8K - $17.4K
|
|
|
Q2 2022
Filed on Aug 08, 2022
|
200
|
$26.74 - $35.19
$5.35K - $7.04K
|
|
|
Q2 2022
Filed on Aug 08, 2022
|
25
|
$16.01 - $27.99
$400 - $700
|
|
|
Q2 2022
Filed on Aug 08, 2022
|
1,011
|
$31.05 - $60.75
$31.4K - $61.4K
|
|
|
Q2 2022
Filed on Aug 08, 2022
|
400
|
$0.86 - $2.06
$344 - $824
|
|
|
Q1 2022
Filed on May 04, 2022
|
60,792
|
N/A
|
|
|
Q1 2022
Filed on May 04, 2022
|
27,689
|
$44.64 - $55.71
$1.24M - $1.54M
|
|
|
Q1 2022
Filed on May 04, 2022
|
8,671
|
N/A
|
|
|
Q1 2022
Filed on May 04, 2022
|
44,321
|
N/A
|
|
|
Q1 2022
Filed on May 04, 2022
|
11,761
|
N/A
|
|
Invesco Exchange Traded Fd T
|
Q1 2022
Filed on May 04, 2022
|
11,313
|
N/A
|
|
|
Q1 2022
Filed on May 04, 2022
|
2,975
|
$97.11 - $106.16
$289K - $316K
|
|
|
Q1 2022
Filed on May 04, 2022
|
18,042
|
$45.4 - $54.71
$819K - $987K
|
|
|
Q1 2022
Filed on May 04, 2022
|
1,470
|
$89.67 - $105.46
$132K - $155K
|
|
|
Q1 2022
Filed on May 04, 2022
|
26,783
|
$25.04 - $38.88
$671K - $1.04M
|
|
|
Q1 2022
Filed on May 04, 2022
|
11,559
|
$184.81 - $224.78
$2.14M - $2.6M
|
|
|
Q1 2022
Filed on May 04, 2022
|
5,300
|
$49.44 - $52.65
$262K - $279K
|
|
|
Q1 2022
Filed on May 04, 2022
|
48,689
|
$52.09 - $56.27
$2.54M - $2.74M
|
|
|
Q4 2021
Filed on Feb 10, 2022
|
16,017
|
N/A
|
|
Invesco Exch Trd Slf Idx Fd
|
Q4 2021
Filed on Feb 10, 2022
|
131,283
|
N/A
|
|
Invesco Exch Trd Slf Idx Fd
|
Q4 2021
Filed on Feb 10, 2022
|
72,327
|
N/A
|
|
|
Q4 2021
Filed on Feb 10, 2022
|
8,965
|
N/A
|
|
|
Q4 2021
Filed on Feb 10, 2022
|
12,843
|
N/A
|
|
|
Q4 2021
Filed on Feb 10, 2022
|
20,250
|
$31.98 - $36.4
$648K - $737K
|
|
|
Q4 2021
Filed on Feb 10, 2022
|
40,731
|
$1.03 - $2.31
$42K - $94.1K
|
|
Nuveen Tax Advantaged Divid
|
Q4 2021
Filed on Feb 10, 2022
|
15,950
|
N/A
|
|
Trillium Therapeutics Inc
|
Q4 2021
Filed on Feb 10, 2022
|
18,625
|
N/A
|
|
|
Q4 2021
Filed on Feb 10, 2022
|
5,199
|
$129.77 - $176.4
$675K - $917K
|
|
|
Q4 2021
Filed on Feb 10, 2022
|
2,058
|
$174.93 - $227.37
$360K - $468K
|
|
|
Q3 2021
Filed on Nov 12, 2021
|
90,781
|
N/A
|
|
|
Q3 2021
Filed on Nov 12, 2021
|
2,775
|
$100.08 - $100.11
$278K - $278K
|
|
|
Q3 2021
Filed on Nov 12, 2021
|
1,548
|
N/A
|
|
Alexion Pharmaceuticals Inc
|
Q3 2021
Filed on Nov 12, 2021
|
1,989
|
N/A
|
|
|
Q3 2021
Filed on Nov 12, 2021
|
31,400
|
$16.87 - $20.76
$530K - $652K
|
|
|
Q3 2021
Filed on Nov 12, 2021
|
3,242
|
$109.27 - $129.35
$354K - $419K
|
|
|
Q3 2021
Filed on Nov 12, 2021
|
10,845
|
N/A
|
|
|
Q3 2021
Filed on Nov 12, 2021
|
6,907
|
N/A
|
|
|
Q3 2021
Filed on Nov 12, 2021
|
40,537
|
$49.96 - $50.23
$2.03M - $2.04M
|
|
|
Q3 2021
Filed on Nov 12, 2021
|
3,043
|
$105.0 - $178.37
$320K - $543K
|
|
|
Q3 2021
Filed on Nov 12, 2021
|
10,600
|
$11.07 - $14.0
$117K - $148K
|
|
|
Q3 2021
Filed on Nov 12, 2021
|
16,458
|
$36.9 - $50.66
$607K - $834K
|
|
|
Q3 2021
Filed on Nov 12, 2021
|
85,884
|
$39.75 - $49.17
$3.41M - $4.22M
|
|
|
Q3 2021
Filed on Nov 12, 2021
|
2,456
|
N/A
|
|
|
Q3 2021
Filed on Nov 12, 2021
|
2,464
|
$114.77 - $123.33
$283K - $304K
|
|
|
Q3 2021
Filed on Nov 12, 2021
|
4,672
|
N/A
|
|